Top

Journal of Public Health

Published in:

Open Access 21-10-2021 | Heart Failure | Original Article

The risk of non-steroidal anti-inflammatory drug-induced heart failure in people with chronic kidney disease: a systematic review

Authors: Bethany S. Ward, Michael Naughton, Dorothea Nitsch, Mariam Molokhia

Published in: Journal of Public Health | Issue 7/2022

Abstract

Aim

To examine the risk of non-steroidal anti-inflammatory drug-induced heart failure in patients with chronic kidney disease.

Methods

Embase, Medline, CENTRAL, Web of Science, and Google Scholar were searched for papers published in English between 1st January 1999 and 31st May 2020. Papers were included if some participants had chronic kidney disease, were exposed to non-steroidal anti-inflammatory drugs, and where heart failure was measured as an outcome. Papers were assessed for risk of bias using the Cochrane Risk of Bias 2 tool for randomised controlled trials, and ROBINS-I for observational studies.

Results

A total of 2480 independent papers were retrieved. Following abstract screening, 165 full texts were reviewed to identify seven eligible papers: two randomised controlled trials, four cohort studies, and one case-control study. For chronic kidney disease (stage 3–5), relative risk for heart failure ranged from 0.3 to 1.9 with 95% confidence interval 0.04 to 15.1. Results were not pooled due to study heterogeneity. We attributed bias to heterogenous populations studied, probable confounding due to partially adjusted risk estimates, and heterogenous measurement of the heart failure outcome.

Conclusion

Overall, there are only a few studies to refute or support an increased risk of heart failure associated with taking non-steroidal anti-inflammatory drugs in patients with chronic kidney disease, and therefore no robust evidence was available.

Available only for authorised users

Arfè A, Scotti L, Varas-Lorenzo C et al (2016)Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case–control study. BMJ 354:i4857. https://doi.org/10.1136/bmj.i4857 CrossRefPubMed

BMJ (2020) Study design search filters. https://bestpractice.bmj.com/info/us/toolkit/learn-ebm/study-design-search-filters. Accessed 19 October 2019

Coxib and traditional NSAID Trialists’ (CNT) Collaboration (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382(9894):769–779. https://doi.org/10.1016/S0140-6736(13)60900-9 CrossRef

EBM Data Lab University of Oxford (2020)Non-steroidal anti-inflammatory drugs. https://openprescribing.net/bnf/100101. Accessed 12 January 2020

Fayaz A, Croft P, Langford RM, Donaldson LJ, Jones GT (2016) Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open 6:e010364. https://doi.org/10.1136/bmjopen-2015-010364 CrossRefPubMedPubMedCentral

García Rodríguez LA, Hernández-Díaz S (2003) Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure. Epidemiology 14(2):240–246. https://doi.org/10.1097/01.EDE.0000034633.74133.C3 CrossRefPubMed

Goicoechea M, de Vinuesa G, Quiroga B et al (2018) Aspirin for the primary prevention of cardiovascular disease and renal disease progression in chronic kidney disease patients: a multicentre randomised clinical trial (AASER study). Cardiovasc Drugs Ther 32:255–263. https://doi.org/10.1007/s10557-018-6802-1 CrossRefPubMed

Hill NR, Fatoba S, Oke J et al (2016) Global prevalence of chronic kidney disease- a systematic review and meta-analysis. PLoS One 11(7):e0158765. https://doi.org/10.1371/journal.pone.0158765

Iwagami M, Caplin B, Smeeth L, Tomlinson LA, Nitsch D (2018) Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data. Br J Gen Pract 68(673):e512–e523. https://doi.org/10.3399/bjgp18X697973 CrossRefPubMedPubMedCentral

Kim AJ, Lim HJ, Ro H et al (2014)Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease. PLoS One 9(8):e104179. https://doi.org/10.1371/journal.pone.0104179 CrossRefPubMedPubMedCentral

Kottgen A, Russell SD, Loehr LR et al (2007) Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Nephrol 18(4):1307–1315. https://doi.org/10.1681/ASN.2006101159 CrossRefPubMed

Lai Y-H et al (2017) Hazards of antithrombotic therapy on hemodialysis patients with atrial fibrillation and high thromboembolic risk: a Taiwanese population-based cohort study. Int J Clin Exp Med 10(9):13982–13991

Lefebvre C, Hindié J, Zappitelli M, Platt RW, Filion KB (2019)Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care. Clin Kidney J 13(1):63–71. https://doi.org/10.1093/ckj/sfz054 CrossRefPubMedPubMedCentral

Levy D, Kenchaiah S, Larson MG et al (2002)Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347(18):1397–1402. https://doi.org/10.1056/NEJMoa020265 CrossRefPubMed

Liu J, Pan Y, Chen L et al (2016)Low-dose aspirin for prevention of cardiovascular disease in patients on haemodialysis: a 5-y prospective cohort study. Haemodial Int 20(4):548–557. https://doi.org/10.1111/hdi.12409 CrossRef

Marks, J. L, Colebatch A, Buchbinder R, Edwards C (2011) Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity. Cochrane Database Syst Rev (10):CD008952. http://doi.wiley.com/10.1002/14651858.CD008952.pub2

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535 CrossRefPubMedPubMedCentral

National Institute for Health and Care Excellence (2021) Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. NICE, London. https://www.nice.org.uk/guidance/ng193. Accessed 24 April 2021

National Institute for Health Research (2018) An aspirin a day for chronic kidney disease. NIHR, Leeds, UK. https://www.nihr.ac.uk/blog/an-aspirin-a-day-for-chronic-kidney-disease/11104. Accessed 21 April 2021

Nguyen N, Cockwell P, Maxwell AP et al (2018) Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England. PLoS One 13(11):e0207960. https://doi.org/10.1371/journal.pone.0207960 CrossRefPubMedPubMedCentral

Qu B, He Y, Wu L et al (2020) Is there a cardiovascular protective effect of aspirin in chronic kidney disease patients? A systematic review and meta-analysis. Int Urol Nephrol 52(2):315–324. https://doi.org/10.1007/s11255-019-02350-8 CrossRefPubMed

Siemieniuk R, Guyatt G (2021) What is GRADE? BMJ publishing group limited 2021. https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade. Accessed 13 May 2020

Sinsakul M, Sika M, Rodby R et al (2007) A randomised trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease. Am J Kidney Dis 50(6):946–951. https://doi.org/10.1053/j.ajkd.2007.09.005 CrossRefPubMed

Sterne JAC, Savović J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898

Sterne JAC, Hernán MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https://doi.org/10.1136/bmj.i4919

Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC et al (2003) Heart failure as a cause for hospitalisation in chronic dialysis patients. Am J Kidney Dis 41(6):1267–1277. https://doi.org/10.1016/s0272-6386(03)00359-7 CrossRefPubMed

Wu J, Ginsberg JS, Zhan M et al (2015) Chronic pain and analgesic use in CKD: implications for patient safety. Clin J Am Soc Nephrol 10(3):435–442. https://doi.org/10.2215/CJN.06520714 CrossRefPubMedPubMedCentral

Zhang Q-L, Rothenbacher D (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8:117. https://doi.org/10.1186/1471-2458-8-117

Zhang X, Donnan PT, Bell S et al (2017)Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol 18:256. https://doi.org/10.1186/s12882-017-0673-8 CrossRefPubMedPubMedCentral

Title: The risk of non-steroidal anti-inflammatory drug-induced heart failure in people with chronic kidney disease: a systematic review
Authors: Bethany S. Ward
Michael Naughton
Dorothea Nitsch
Mariam Molokhia
Publication date: 21-10-2021
Publisher: Springer Berlin Heidelberg
Keywords: Heart Failure
Chronic Kidney Disease
Published in: Journal of Public Health / Issue 7/2022
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI: https://doi.org/10.1007/s10389-021-01654-3

Keynote Webinar | Spotlight on Diet and Diabetes

Springer Medicine

The risk of non-steroidal anti-inflammatory drug-induced heart failure in people with chronic kidney disease: a systematic review

Abstract

Aim

Methods

Results

Conclusion

Keynote Webinar | Spotlight on Diet and Diabetes

Springer Medicine

Abstract

Aim

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2022

Economic costs of cigarette smoking among adolescents in Nigeria

A comparative study of quality of health care services of public and private hospitals in Ghana

Risk of developing type 2 diabetes according to FINDRISC and socioeconomic status

Quality of life and the related factors in Iranian transgender people: a cross-sectional study

Measuring and understanding public awareness of fetal alcohol spectrum disorders in Alberta, Canada

Breast cancer awareness and knowledge assessment among men and women in Malaysia